← Eichor
Study identifier: NCT04117334 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Determining Best Indications for Bracing for Adolescent Idiopathic Scoliosis

Condition: Adolescent Idiopathic Scoliosis  ·  Sponsor: The University of Hong Kong

PhaseN/A
Planned participants700
Who can joinAll sexes, 10 Years to 18 Years
Healthy volunteersNo

About this study

This is a prospective study for Investigating the cost-effectiveness of current bracing protocols for adolescent idiopathic scoliosis (AIS). It is hypothesized that aggressive management of adolescent idiopathic scoliosis (AIS) including early bracing at mild curve magnitudes and surgery at 40 degrees is more cost-effective while maintaining similar health quality of life. Scoliosis Research Society 22-item and EuroQol- 5 dimension questionnaires and direct/indirect medical costs will be utilized for the cost-effectiveness analysis and health related quality of life assessment. The findings of this study have the potential to improve decision-making and revolutionize care of AIS patients in Hong Kong and globally. Clinicians will be able to utilize our results to provide the best and most cost-effective timing for initiating brace treatment.

This description comes directly from the study's public registry record.

Talk to the study team

Jason Cheung, MBBS, MS  ·  (852)22554581  ·  cheungjp@hku.hk

Always discuss trial participation with your own doctor first.

Locations (2)

Duchess of Kent Children's HospitalHong Kong, Hong KongRecruiting
Jason Pui Yin CheungHong Kong, Hong KongRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04117334